DR. ANDREW LEO SOCHACKI M.D. NPI 1003235391

NPI Details

DR. Andrew Leo Sochacki, M.D. is a hematology and oncology internal medicine in Grand Rapids, MI with 11 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Andrew Leo Sochacki, M.D. NPI is 1003235391. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MICHIGAN STATE UNIVERSITY COLLEGE OF HUMAN MEDICINE
Graduation Year:2014

The provider's business location address is:

5800 FOREMOST DR SE STE 200
GRAND RAPIDS, MI
ZIP 49546-062
Phone: (616) 389-1800

The NPI 1003235391 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Uric acid level, blood (HCPCS:84550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Protein measurement, serum (HCPCS:84165)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Blood test, clotting time (HCPCS:85610)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Magnesium level (HCPCS:83735)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody measurement (HCPCS:86704)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Beta-2 microglobulin (protein) level (HCPCS:82232)

The enumeration date for this NPI number is 4/15/2014 and was last updated on 7/1/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: